Streetbeat News

Equity Actions

CDZI

Cadiz, Inc. has partnered with MZ Group to enhance its investor relations and financial communications strategy. This move comes at a critical inflection point under the new leadership of Susan Kennedy, highlighted by significant permitting and contracting milestones. Additionally, a recent Form 4 filing revealed the CEO's purchase of Cadiz shares, aligning interests with shareholders.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 1:30 pm

TIVC

Tivic Health Systems Inc. has announced the pricing of a $4 million public offering, aiming to raise funds for general corporate purposes, including working capital. This move could indicate the company's need for financial strengthening or expansion efforts.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 1:27 pm

CMPO

CompoSecure, Inc. (NASDAQ:CMPO) announced a secondary offering of 7M shares of Class A common stock at $6.50/share by Selling Shareholders, totaling $45.5M. CompoSecure will not receive proceeds from the sale. The offering, managed by J.P. Morgan, BofA Securities, and TD Cowen, with B. Riley Securities, Needham & Company, and Roth Capital Partners as co-managers, is expected to close on May 13, 2024.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 1:24 pm

ARGT

EEM

Elon Musk recommends investing in Argentina, citing a risk-on market trend. Argentina's President Javier Milei's economic reforms have led to significant interest rate cuts and a bullish outlook for the Global X MSCI Argentina ETF (ARGT), despite it being overbought. The ARGT ETF has outperformed the S&P 500 and the iShares MSCI Emerging Markets Index (EEM) this year. However, geopolitical tensions and potential policy adjustments pose risks to ARGT's momentum.

Portfolio Pulse from Kenneth Rapoza

May 09, 2024 | 1:24 pm

FVRR

In the last three months, 8 analysts have evaluated Fiverr Intl (NYSE:FVRR), showing a mix of bullish and indifferent sentiments. The recent ratings indicate a shift towards a more cautious outlook, with a current average price target of $30.88, down 8.29% from the previous target. Analysts from firms like Needham, BTIG, JP Morgan, Citigroup, RBC Capital, and Piper Sandler have adjusted their price targets and ratings, reflecting changes in market conditions and Fiverr's performance. Fiverr's financials show a notable revenue growth of 10.07% over the past 3 months, a net margin of 5.14%, but lower than average ROE and ROA, and a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

May 09, 2024 | 1:01 pm

PIRS

Pieris Pharmaceuticals (NYSE:PIRS) has seen a significant increase in short interest, with a 1664.29% rise since the last report, reaching 24 thousand shares or 2.47% of the float. This suggests a bearish market sentiment, although it's below the peer group average of 2.73%. The coverage time for short positions based on trading volume is approximately 1 day.

Portfolio Pulse from Benzinga Insights

May 09, 2024 | 1:00 pm

MBRX

Moleculin Biotech has received a notification from the U.S. Patent and Trademark Office for a patent titled, "Method of Reconstituting Liposomal Annamycin," which will provide composition protection through 2040, potentially extending further. Annamycin is moving towards a pivotal AML study in 2024 and may be eligible for an accelerated approval pathway.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 12:43 pm

ONVO

Organovo Holdings announced a public offering of 6,562,500 shares and common warrants, totaling $5.25 million, leading to a decrease in its share price.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 12:21 pm

SN

SharkNinja has updated its FY24 financial outlook, projecting an increase in adjusted net income per diluted share to $3.66-$3.82 from a prior estimate of $3.45-$3.61. Adjusted net sales are expected to grow 12%-14% YoY, up from the previous 7%-9% forecast. Adjusted EBITDA is anticipated to be between $840 million and $870 million, marking a 17%-21% increase from the prior year. The company also expects a GAAP effective tax rate of 24%-25%, diluted weighted average shares outstanding of approximately 141 million, and capital expenditures of $160 million to $180 million.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 12:20 pm

BLBD

Blue Bird (NASDAQ:BLBD) has received updated analyst ratings, with a unanimous bullish outlook from 4 analysts. The average 12-month price target is now $45.00, up from $39.50, indicating a 13.92% increase. Recent actions include price target raises by analysts from Needham and Roth MKM, reflecting positive sentiment towards Blue Bird's financial performance and market position. The company has shown impressive revenue growth, net margin, ROE, and ROA, although its debt-to-equity ratio suggests financial challenges.

Portfolio Pulse from Benzinga Insights

May 09, 2024 | 12:01 pm